Anita Chong to Animals
This is a "connection" page, showing publications Anita Chong has written about Animals.
Connection Strength
2.422
-
Hyporesponsive fetus-specific T cell responses in multiparous human pregnancy. Front Immunol. 2025; 16:1634430.
Score: 0.056
-
CAR Treg synergy with anti-CD154 promotes infectious tolerance and dictates allogeneic heart transplant acceptance. JCI Insight. 2025 04 08; 10(7).
Score: 0.055
-
Cutting to the chase: Pruning alloreactive T cells. Immunity. 2025 02 11; 58(2):270-272.
Score: 0.055
-
Update on the immunological mechanisms of primary graft dysfunction and chronic lung allograft dysfunction. Curr Opin Organ Transplant. 2024 Dec 01; 29(6):412-419.
Score: 0.053
-
Pregnancy dedifferentiates memory CD8+ T cells into hypofunctional cells with exhaustion-enriched programs. JCI Insight. 2024 05 21; 9(13).
Score: 0.052
-
MHC Tetramers Specifically Identify High- and Low-avidity Donor-specific B Cells in Transplantation Tolerance and Rejection. Transplantation. 2023 12 01; 107(12):2526-2532.
Score: 0.050
-
Lung cDC1 and cDC2 dendritic cells priming naive CD8+ T cells in situ prior to migration to draining lymph nodes. Cell Rep. 2023 10 31; 42(10):113299.
Score: 0.050
-
A novel triptolide analog downregulates NF-?B and induces mitochondrial apoptosis pathways in human pancreatic cancer. Elife. 2023 10 25; 12.
Score: 0.050
-
Beyond Adaptive Alloreactivity: Contribution of Innate B Cells to Allograft Inflammation and Rejection. Transplantation. 2023 01 01; 107(1):98-104.
Score: 0.047
-
From bench to bedside: reversing established antibody responses and desensitization. Curr Opin Organ Transplant. 2022 10 01; 27(5):376-384.
Score: 0.046
-
Linked sensitization by memory CD4+ T cells prevents costimulation blockade-induced transplantation tolerance. JCI Insight. 2022 06 08; 7(11).
Score: 0.045
-
Pregnancy-induced humoral sensitization overrides T cell tolerance to fetus-matched allografts in mice. J Clin Invest. 2021 01 04; 131(1).
Score: 0.041
-
Transplantation tolerance modifies donor-specific B cell fate to suppress de novo alloreactive B cells. J Clin Invest. 2020 07 01; 130(7):3453-3466.
Score: 0.040
-
B cells as antigen-presenting cells in transplantation rejection and tolerance. Cell Immunol. 2020 03; 349:104061.
Score: 0.039
-
New insights into the development of B cell responses: Implications for solid organ transplantation. Hum Immunol. 2019 Jun; 80(6):378-384.
Score: 0.035
-
Evolving Approaches in the Identification of Allograft-Reactive T and B Cells in Mice and Humans. Transplantation. 2017 11; 101(11):2671-2681.
Score: 0.033
-
Transplantation tolerance: don't forget about the B cells. Clin Exp Immunol. 2017 08; 189(2):171-180.
Score: 0.031
-
Tracing Donor-MHC Class II Reactive B cells in Mouse Cardiac Transplantation: Delayed CTLA4-Ig Treatment Prevents Memory Alloreactive B-Cell Generation. Transplantation. 2016 08; 100(8):1683-91.
Score: 0.030
-
Erosion of Transplantation Tolerance After Infection. Am J Transplant. 2017 01; 17(1):81-90.
Score: 0.030
-
Delayed Cytotoxic T Lymphocyte-Associated Protein 4-Immunoglobulin Treatment Reverses Ongoing Alloantibody Responses and Rescues Allografts From Acute Rejection. Am J Transplant. 2016 08; 16(8):2312-23.
Score: 0.030
-
Cutting Edge: CTLA-4Ig Inhibits Memory B Cell Responses and Promotes Allograft Survival in Sensitized Recipients. J Immunol. 2015 Nov 01; 195(9):4069-73.
Score: 0.028
-
Spontaneous restoration of transplantation tolerance after acute rejection. Nat Commun. 2015 Jul 07; 6:7566.
Score: 0.028
-
Memory B cells in transplantation. Transplantation. 2015 Jan; 99(1):21-8.
Score: 0.027
-
Titrating T-cell epitopes within self-assembled vaccines optimizes CD4+ helper T cell and antibody outputs. Adv Healthc Mater. 2014 Nov; 3(11):1898-908.
Score: 0.026
-
Transplantation tolerance and its outcome during infections and inflammation. Immunol Rev. 2014 Mar; 258(1):80-101.
Score: 0.026
-
Microbes and allogeneic transplantation. Transplantation. 2014 Jan 15; 97(1):5-11.
Score: 0.025
-
Lessons and limits of mouse models. Cold Spring Harb Perspect Med. 2013 Dec 01; 3(12):a015495.
Score: 0.025
-
Reversing endogenous alloreactive B cell GC responses with anti-CD154 or CTLA-4Ig. Am J Transplant. 2013 Sep; 13(9):2280-92.
Score: 0.024
-
Enhancing pancreatic Beta-cell regeneration in vivo with pioglitazone and alogliptin. PLoS One. 2013; 8(6):e65777.
Score: 0.024
-
The impact of infection and tissue damage in solid-organ transplantation. Nat Rev Immunol. 2012 May 25; 12(6):459-71.
Score: 0.023
-
Three Strikes and You're Cured. Sci Transl Med. 2012 May 09; 4(133):133fs12.
Score: 0.023
-
Matchmaking the B-cell signature of tolerance to regulatory B cells. Am J Transplant. 2011 Dec; 11(12):2555-60.
Score: 0.022
-
Experimental models of B cell tolerance in transplantation. Semin Immunol. 2012 Apr; 24(2):77-85.
Score: 0.022
-
IL-6 induced by Staphylococcus aureus infection prevents the induction of skin allograft acceptance in mice. Am J Transplant. 2011 May; 11(5):936-46.
Score: 0.021
-
Making a B-line for transplantation tolerance. Am J Transplant. 2011 Mar; 11(3):420-1.
Score: 0.021
-
Alloantibodies prevent the induction of transplantation tolerance by enhancing alloreactive T cell priming. J Immunol. 2011 Jan 01; 186(1):214-21.
Score: 0.020
-
Infection with the intracellular bacterium, Listeria monocytogenes, overrides established tolerance in a mouse cardiac allograft model. Am J Transplant. 2010 Jul; 10(7):1524-33.
Score: 0.020
-
Seeing is believing: how the MIP-luc mouse can advance the field of islet transplantation and ß-cell regeneration. Islets. 2010 Jul-Aug; 2(4):261-2.
Score: 0.020
-
Glycemic control promotes pancreatic beta-cell regeneration in streptozotocin-induced diabetic mice. PLoS One. 2010 Jan 18; 5(1):e8749.
Score: 0.019
-
Memory alloreactive B cells and alloantibodies prevent anti-CD154-mediated allograft acceptance. J Immunol. 2009 Feb 01; 182(3):1314-24.
Score: 0.018
-
Toll-like receptor signaling in transplantation. Curr Opin Organ Transplant. 2008 Aug; 13(4):358-65.
Score: 0.017
-
Prevention of allograft tolerance by bacterial infection with Listeria monocytogenes. J Immunol. 2008 May 01; 180(9):5991-9.
Score: 0.017
-
Long-term control of alloreactive B cell responses by the suppression of T cell help. J Immunol. 2008 May 01; 180(9):6077-84.
Score: 0.017
-
Cellular therapies for type 1 diabetes. Horm Metab Res. 2008 Feb; 40(2):147-54.
Score: 0.017
-
Hyperacute rejection by anti-Gal IgG1, IgG2a, and IgG2b is dependent on complement and Fc-gamma receptors. J Immunol. 2008 Jan 01; 180(1):261-8.
Score: 0.017
-
Expression of complement regulatory proteins in accommodated xenografts induced by anti-alpha-Gal IgG1 in a rat-to-mouse model. Am J Transplant. 2008 Jan; 8(1):32-40.
Score: 0.016
-
Peripheral deletion of mature alloreactive B cells induced by costimulation blockade. Proc Natl Acad Sci U S A. 2007 Jul 17; 104(29):12093-8.
Score: 0.016
-
Recovery of islet beta-cell function in streptozotocin- induced diabetic mice: an indirect role for the spleen. Diabetes. 2006 Dec; 55(12):3256-63.
Score: 0.015
-
TLR engagement prevents transplantation tolerance. Am J Transplant. 2006 Oct; 6(10):2282-91.
Score: 0.015
-
APOL1 risk alleles modulate T cell receptor signaling to promote allograft rejection. J Clin Invest. 2026 Aug 03; 136(15).
Score: 0.015
-
Dual induction of tissue-resident T and B cell immunity for broad influenza protection with a nanofiber-VLP vaccine. J Nanobiotechnology. 2026 Mar 30; 24(1).
Score: 0.015
-
Reversal of diabetes in non-obese diabetic mice without spleen cell-derived beta cell regeneration. Science. 2006 Mar 24; 311(5768):1774-5.
Score: 0.015
-
Mechanisms of donor-specific transfusion synergy with anti-CD154 for transplant acceptance. J Immunol. 2026 03 17; 215(3).
Score: 0.015
-
Liver ischemia contributes to early islet failure following intraportal transplantation: benefits of liver ischemic-preconditioning. Am J Transplant. 2006 Jan; 6(1):60-8.
Score: 0.015
-
Concurrent antiviral and immunosuppressive activities of leflunomide in vivo. Am J Transplant. 2006 Jan; 6(1):69-75.
Score: 0.015
-
Multi-omics analysis of a pig-to-human decedent kidney xenotransplant. Nature. 2026 02; 650(8100):205-217.
Score: 0.014
-
Cell-intrinsic CD4 T cell tolerance: a new frontier in therapy? Trends Immunol. 2025 09; 46(9):624-634.
Score: 0.014
-
Follicular regulatory T cells restrain kidney allograft rejection in mice by suppressing alloreactive B cells. Nat Commun. 2025 Mar 04; 16(1):2151.
Score: 0.014
-
Isolation and transcriptional profiling of antigen-presenting cells from mouse lung and MLNs following intranasal immunization. STAR Protoc. 2024 12 20; 5(4):103400.
Score: 0.013
-
Cutting Edge: NK cells mediate IgG1-dependent hyperacute rejection of xenografts. J Immunol. 2004 Jun 15; 172(12):7235-8.
Score: 0.013
-
Integrative multi-omics profiling in human decedents receiving pig heart xenografts. Nat Med. 2024 05; 30(5):1448-1460.
Score: 0.013
-
Low-affinity CD8+ T cells provide interclonal help to high-affinity CD8+ T cells to augment alloimmunity. Am J Transplant. 2024 Jun; 24(6):933-943.
Score: 0.013
-
Advancing mouse models for transplantation research. Am J Transplant. 2024 Aug; 24(8):1362-1368.
Score: 0.013
-
Heterogeneity in allospecific T cell function in transplant-tolerant hosts determines susceptibility to rejection following infection. J Clin Invest. 2023 11 01; 133(21).
Score: 0.012
-
IL-21-producing effector Tfh cells promote B cell alloimmunity in lymph nodes and kidney allografts. JCI Insight. 2023 10 23; 8(20).
Score: 0.012
-
Donor programmed cell death 1 ligand 1 is required for organ transplant tolerance in major histocompatibility complex-mismatched mixed chimeras although programmed cell death 1 ligand 1 and major histocompatibility complex class II are not required for inducing chimerism. Am J Transplant. 2023 08; 23(8):1116-1129.
Score: 0.012
-
The in vitro and in vivo effects of anti-galactose antibodies on endothelial cell activation and xenograft rejection. J Immunol. 2003 Feb 01; 170(3):1531-9.
Score: 0.012
-
IFN-gamma production is specifically regulated by IL-10 in mice made tolerant with anti-CD40 ligand antibody and intact active bone. J Immunol. 2003 Jan 15; 170(2):853-60.
Score: 0.012
-
Role of CD4+ and CD8+ T cells in the rejection of concordant pancreas xenografts. Transplantation. 2002 Nov 15; 74(9):1236-41.
Score: 0.012
-
Transcriptionally Distinct B Cells Infiltrate Allografts After Kidney Transplantation. Transplantation. 2023 02 01; 107(2):e47-e57.
Score: 0.012
-
Reduced Satb1 expression predisposes CD4+ T conventional cells to Treg suppression and promotes transplant survival. Proc Natl Acad Sci U S A. 2022 10 04; 119(40):e2205062119.
Score: 0.012
-
Host-versus-commensal immune responses participate in the rejection of colonized solid organ transplants. J Clin Invest. 2022 09 01; 132(17).
Score: 0.012
-
Allograft tolerance induced by intact active bone co-transplantation and anti-CD40L monoclonal antibody therapy. Transplantation. 2002 Aug 15; 74(3):345-54.
Score: 0.011
-
Tissue specificity drives protective immunity against Staphylococcus aureus infection. Front Immunol. 2022; 13:795792.
Score: 0.011
-
Acute xenograft rejection mediated by antibodies produced independently of TH1/TH2 cytokine profiles. Am J Transplant. 2002 Jul; 2(6):526-34.
Score: 0.011
-
Oral alloantigen exposure promotes donor-specific tolerance in a mouse model of minor-mismatched skin transplantation. Am J Transplant. 2022 10; 22(10):2348-2359.
Score: 0.011
-
Intact active bone transplantation synergizes with anti-CD40 ligand therapy to induce B cell tolerance. J Immunol. 2002 May 15; 168(10):5352-8.
Score: 0.011
-
CTLA-41g in combination with anti-CD40L prolongs xenograft survival and inhibits anti-gal ab production in GT-Ko mice. Am J Transplant. 2002 Jan; 2(1):41-7.
Score: 0.011
-
Innate-like self-reactive B cells infiltrate human renal allografts during transplant rejection. Nat Commun. 2021 07 16; 12(1):4372.
Score: 0.011
-
Lewis rat pancreas, but not cardiac xenografts, are resistant to anti-gal antibody mediated hyperacute rejection. Transplantation. 2001 May 27; 71(10):1385-9.
Score: 0.011
-
Non-depleting anti-CD4, but not anti-CD8, antibody induces long-term survival of xenogeneic and allogeneic hearts in alpha1,3-galactosyltransferase knockout (GT-Ko) mice. Xenotransplantation. 2000 Nov; 7(4):275-83.
Score: 0.010
-
Anti-galactose-alpha(1,3)Galactose antibody production in alpha1, 3-galactosyltransferase gene knockout mice after xeno- and allotransplantation. Transplant Proc. 2000 Aug; 32(5):844-5.
Score: 0.010
-
Efficacy of FK506, leflunomide, anti-CD4, and CTLA4IG treatments in rat to mouse pancreas xenograft transplantation. Transplant Proc. 2000 Aug; 32(5):1003-4.
Score: 0.010
-
Nondepleting anti-CD4 but not anti-CD8 antibody induces long-term survival of xenogeneic and allogeneic hearts in alpha1, 3-galactosyl-transferase knock-out mice. Transplant Proc. 2000 Aug; 32(5):1005.
Score: 0.010
-
Anti-galactose-alpha(1,3) galactose antibody production in alpha1,3-galactosyltransferase gene knockout mice after xeno and allo transplantation. Transpl Immunol. 2000 Jun; 8(2):129-37.
Score: 0.010
-
Reversing donor-specific antibody responses and antibody-mediated rejection with bortezomib and belatacept in mice and kidney transplant recipients. Am J Transplant. 2020 10; 20(10):2675-2685.
Score: 0.010
-
Inhibition of protective immunity against Staphylococcus aureus infection by MHC-restricted immunodominance is overcome by vaccination. Sci Adv. 2020 04; 6(14):eaaw7713.
Score: 0.010
-
Enabling sublingual peptide immunization with molecular self-assemblies. Biomaterials. 2020 05; 241:119903.
Score: 0.010
-
Tolerance of T-independent xeno-antibody responses in the hamster-to-rat xenotransplantation model is species-restricted but not tissue-specific. Xenotransplantation. 2000 Feb; 7(1):48-57.
Score: 0.010
-
Resilience of T cell-intrinsic dysfunction in transplantation tolerance. Proc Natl Acad Sci U S A. 2019 11 19; 116(47):23682-23690.
Score: 0.009
-
In vitro and in vivo antitumor activity of a novel immunomodulatory drug, leflunomide: mechanisms of action. Biochem Pharmacol. 1999 Nov 01; 58(9):1405-13.
Score: 0.009
-
Skin-restricted commensal colonization accelerates skin graft rejection. JCI Insight. 2019 07 16; 5.
Score: 0.009
-
In vivo activity of leflunomide: pharmacokinetic analyses and mechanism of immunosuppression. Transplantation. 1999 Jul 15; 68(1):100-9.
Score: 0.009
-
The pursuit of transplantation tolerance: new mechanistic insights. Cell Mol Immunol. 2019 04; 16(4):324-333.
Score: 0.009
-
Inhibition of cytomegalovirus in vitro and in vivo by the experimental immunosuppressive agent leflunomide. Intervirology. 1999; 42(5-6):412-8.
Score: 0.009
-
Distinct Graft-Specific TCR Avidity Profiles during Acute Rejection and Tolerance. Cell Rep. 2018 08 21; 24(8):2112-2126.
Score: 0.009
-
Induction of species-specific host accommodation in the hamster-to-rat xenotransplantation model. J Immunol. 1998 Aug 15; 161(4):2044-51.
Score: 0.009
-
Intranasal delivery of adjuvant-free peptide nanofibers elicits resident CD8+ T cell responses. J Control Release. 2018 07 28; 282:120-130.
Score: 0.009
-
In vitro and in vivo mechanisms of action of the antiproliferative and immunosuppressive agent, brequinar sodium. J Immunol. 1998 Jan 15; 160(2):846-53.
Score: 0.008
-
Modification of humoral responses by the combination of leflunomide and cyclosporine in Lewis rats transplanted with hamster hearts. Transplantation. 1997 Dec 27; 64(12):1650-7.
Score: 0.008
-
Control of lymphoproliferative and autoimmune disease in MRL-lpr/lpr mice by brequinar sodium: mechanisms of action. J Pharmacol Exp Ther. 1997 Nov; 283(2):869-75.
Score: 0.008
-
Active immunotherapy for TNF-mediated inflammation using self-assembled peptide nanofibers. Biomaterials. 2017 Dec; 149:1-11.
Score: 0.008
-
The IRF4 Gene Regulatory Module Functions as a Read-Write Integrator to Dynamically Coordinate T Helper Cell Fate. Immunity. 2017 09 19; 47(3):481-497.e7.
Score: 0.008
-
Quantitation of the changes in splenic architecture during the rejection of cardiac allografts or xenografts. Transplantation. 1997 Aug 15; 64(3):448-53.
Score: 0.008
-
The immunosuppressive metabolite of leflunomide, A77 1726, affects murine T cells through two biochemical mechanisms. J Immunol. 1997 Jul 01; 159(1):22-7.
Score: 0.008
-
In vivo mechanism by which leflunomide controls lymphoproliferative and autoimmune disease in MRL/MpJ-lpr/lpr mice. J Immunol. 1997 Jul 01; 159(1):167-74.
Score: 0.008
-
Self-Antigen-Driven Thymic B Cell Class Switching Promotes T Cell Central Tolerance. Cell Rep. 2016 10 04; 17(2):387-398.
Score: 0.008
-
Vav in natural killer cells is tyrosine phosphorylated upon cross-linking of Fc gamma RIIIA and is constitutively associated with a serine/threonine kinase. Biochem J. 1996 Sep 01; 318 ( Pt 2):527-32.
Score: 0.008
-
Two activities of the immunosuppressive metabolite of leflunomide, A77 1726. Inhibition of pyrimidine nucleotide synthesis and protein tyrosine phosphorylation. Biochem Pharmacol. 1996 Aug 23; 52(4):527-34.
Score: 0.008
-
Delayed xenograft rejection in the concordant hamster heart into Lewis rat model. Transplantation. 1996 Jul 15; 62(1):90-6.
Score: 0.008
-
Receptors that turn on and turn off natural killer cells. J Heart Lung Transplant. 1996 Jul; 15(7):675-83.
Score: 0.008
-
The composition of the microbiota modulates allograft rejection. J Clin Invest. 2016 07 01; 126(7):2736-44.
Score: 0.007
-
Adoptive Transfer of Tracer-Alloreactive CD4+ T Cell Receptor Transgenic T Cells Alters the Endogenous Immune Response to an Allograft. Am J Transplant. 2016 10; 16(10):2842-2853.
Score: 0.007
-
Tracking of TCR-Transgenic T Cells Reveals That Multiple Mechanisms Maintain Cardiac Transplant Tolerance in Mice. Am J Transplant. 2016 10; 16(10):2854-2864.
Score: 0.007
-
High-Fat Diet-Induced Obesity Enhances Allograft Rejection. Transplantation. 2016 05; 100(5):1015-21.
Score: 0.007
-
Complete control of humoral and cell-mediated xenoreactions with the combination of leflunomide and cyclosporine. Transplant Proc. 1996 Apr; 28(2):684.
Score: 0.007
-
Cross-linking of CD45 on NK cells stimulates p56lck-mediated tyrosine phosphorylation and IFN-gamma production. J Immunol. 1995 Dec 01; 155(11):5241-8.
Score: 0.007
-
Proteomic Identification of saeRS-Dependent Targets Critical for Protective Humoral Immunity against Staphylococcus aureus Skin Infection. Infect Immun. 2015 Sep; 83(9):3712-21.
Score: 0.007
-
Inhibition of protein tyrosine phosphorylation in T cells by a novel immunosuppressive agent, leflunomide. J Biol Chem. 1995 May 26; 270(21):12398-403.
Score: 0.007
-
The influence of the microbiota on the immune response to transplantation. Curr Opin Organ Transplant. 2015 Feb; 20(1):1-7.
Score: 0.007
-
Gut microbiota elicits a protective immune response against malaria transmission. Cell. 2014 Dec 04; 159(6):1277-89.
Score: 0.007
-
CD54/ICAM-1 is a costimulator of NK cell-mediated cytotoxicity. Cell Immunol. 1994 Aug; 157(1):92-105.
Score: 0.007
-
Gradated assembly of multiple proteins into supramolecular nanomaterials. Nat Mater. 2014 Aug; 13(8):829-36.
Score: 0.007
-
Leflunomide in experimental transplantation. Control of rejection and alloantibody production, reversal of acute rejection, and interaction with cyclosporine. Transplantation. 1994 Apr 27; 57(8):1223-31.
Score: 0.006
-
Protective immunity against recurrent Staphylococcus aureus skin infection requires antibody and interleukin-17A. Infect Immun. 2014 May; 82(5):2125-34.
Score: 0.006
-
The use of self-adjuvanting nanofiber vaccines to elicit high-affinity B cell responses to peptide antigens without inflammation. Biomaterials. 2013 Nov; 34(34):8776-85.
Score: 0.006
-
B cells assist allograft rejection in the deficiency of protein kinase c-theta. Transpl Int. 2013 Sep; 26(9):919-27.
Score: 0.006
-
Local inflammation exacerbates the severity of Staphylococcus aureus skin infection. PLoS One. 2013; 8(7):e69508.
Score: 0.006
-
Transcriptional regulation of germinal center B and plasma cell fates by dynamical control of IRF4. Immunity. 2013 May 23; 38(5):918-29.
Score: 0.006
-
A self-adjuvanting supramolecular vaccine carrying a folded protein antigen. Adv Healthc Mater. 2013 Aug; 2(8):1114-9.
Score: 0.006
-
Self-assembled peptide nanofibers raising durable antibody responses against a malaria epitope. Biomaterials. 2012 Sep; 33(27):6476-84.
Score: 0.006
-
Modulating adaptive immune responses to peptide self-assemblies. ACS Nano. 2012 Feb 28; 6(2):1557-64.
Score: 0.006
-
TLR signals promote IL-6/IL-17-dependent transplant rejection. J Immunol. 2009 May 15; 182(10):6217-25.
Score: 0.005
-
The multiple facets of toll-like receptors in transplantation biology. Transplantation. 2008 Jul 15; 86(1):1-9.
Score: 0.004
-
The Mll partial tandem duplication: differential, tissue-specific activity in the presence or absence of the wild-type allele. Blood. 2008 Sep 15; 112(6):2508-11.
Score: 0.004
-
CD4+ T cells are sufficient to elicit allograft rejection and major histocompatibility complex class I molecule is required to induce recurrent autoimmune diabetes after pancreas transplantation in mice. Transplantation. 2008 Apr 27; 85(8):1205-11.
Score: 0.004
-
Bioluminescence imaging visualizes activation of nuclear factor-kappaB in mouse cardiac transplantation. Transplantation. 2008 Mar 27; 85(6):903-10.
Score: 0.004
-
American society of transplantation symposium on B cells in transplantation: harnessing humoral immunity from rodent models to clinical practice. Am J Transplant. 2007 Jun; 7(6):1464-70.
Score: 0.004
-
Cell surface receptors for sulphated polysaccharides: a potential marker for macrophage subsets. Immunology. 1986 Jun; 58(2):277-84.
Score: 0.004
-
Nonimmune lymphocyte-macrophage interaction. I. Quantification by an automated colorimetric assay. Cell Immunol. 1985 May; 92(2):265-76.
Score: 0.003
-
Nonimmune lymphocyte-macrophage interaction. II. Evidence that the interaction involves sulfated polysaccharide recognition. Cell Immunol. 1985 May; 92(2):277-89.
Score: 0.003
-
Intratumor depletion of CD4+ cells unmasks tumor immunogenicity leading to the rejection of late-stage tumors. J Exp Med. 2005 Mar 07; 201(5):779-91.
Score: 0.003
-
Mechanistic study of malononitrileamide FK778 in cardiac transplantation and CMV infection in rats. Transplantation. 2005 Jan 15; 79(1):17-22.
Score: 0.003
-
Cutting edge: Cbl-b: one of the key molecules tuning CD28- and CTLA-4-mediated T cell costimulation. J Immunol. 2004 Dec 15; 173(12):7135-9.
Score: 0.003
-
A mouse model for studying intrahepatic islet transplantation. Transplantation. 2004 Aug 27; 78(4):615-8.
Score: 0.003
-
Evidence that tilapia islets do not express alpha-(1,3)gal: implications for islet xenotransplantation. Xenotransplantation. 2004 May; 11(3):276-83.
Score: 0.003
-
Mouse-heart grafts expressing an incompatible carbohydrate antigen. II. Transition from accommodation to tolerance. Transplantation. 2004 Feb 15; 77(3):366-73.
Score: 0.003
-
Skin graft survival in genetically identical cloned pigs. Cloning Stem Cells. 2003; 5(2):117-21.
Score: 0.003
-
Direct killing of xenograft cells by CD8+ T cells of discordant xenograft recipients. Transplantation. 2002 Dec 15; 74(11):1587-95.
Score: 0.003
-
Development and characterization of anti-Gal B cell receptor transgenic Gal-/- mice. Transplantation. 2002 May 27; 73(10):1549-57.
Score: 0.003
-
The structure of anti-Gal immunoglobulin genes in naïve and stimulated Gal knockout mice. Transplantation. 2001 Dec 15; 72(11):1817-25.
Score: 0.003
-
Activation of extracellular signal-regulated kinases potentiates hemin toxicity in astrocyte cultures. J Neurochem. 2001 Nov; 79(3):545-55.
Score: 0.003
-
Combination of antilymphocyte globulin and leflunomide leads to superior grafts. Transplant Proc. 2001 Feb-Mar; 33(1-2):569.
Score: 0.003
-
Inhibition of herpes simplex virus type 1 by the experimental immunosuppressive agent leflunomide. Transplantation. 2001 Jan 15; 71(1):170-4.
Score: 0.003
-
Onset of accumulation of PrPres in murine ME7 scrapie in relation to pathological and PrP immunohistochemical changes. J Comp Pathol. 2001 Jan; 124(1):20-8.
Score: 0.003
-
Differential immune response to carbohydrate epitopes on allo- and xenografts: implications for accommodation. Transplant Proc. 2000 Aug; 32(5):991-3.
Score: 0.002
-
Differential immune responses to alpha-gal epitopes on xenografts and allografts: implications for accommodation in xenotransplantation. J Clin Invest. 2000 Feb; 105(3):301-10.
Score: 0.002
-
The portosystemic shunt protects liver against ischemic reperfusion injury. Transplantation. 1999 Oct 15; 68(7):958-63.
Score: 0.002
-
FK506 treatment in combination with leflunomide in hamster-to-rat heart and liver xenograft transplantation. Transplantation. 1998 Oct 15; 66(7):832-7.
Score: 0.002
-
Histological characterization and pharmacological control of chronic rejection in xenogeneic and allogeneic heart transplantation. Transplantation. 1998 Sep 27; 66(6):692-8.
Score: 0.002
-
Protective effect of ischemic preconditioning on liver preservation-reperfusion injury in rats. Transplantation. 1998 Jul 27; 66(2):152-7.
Score: 0.002
-
Anti-CD4 therapy in combined heart-kidney, heart-liver, and heart-small bowel allotransplants in high-responder rats. Transplantation. 1998 Jul 15; 66(1):1-5.
Score: 0.002
-
Immunosuppression preventing concordant xenogeneic islet graft rejection is not sufficient to prevent recurrence of autoimmune diabetes in nonobese diabetic mice. Transplantation. 1998 May 27; 65(10):1310-4.
Score: 0.002
-
Differential effect of leflunomide on concordant xenogeneic islet graft rejection and recurrence of autoimmune diabetes. Transplant Proc. 1998 Mar; 30(2):463-4.
Score: 0.002
-
Leflunomide-based immunosuppression for porcine islet xenotransplantation. Transplant Proc. 1998 Mar; 30(2):515.
Score: 0.002
-
Effect of gene gun-mediated CTLA4IG and Fas ligand gene transfection on concordant xenogeneic islet graft rejection. Transplant Proc. 1998 Mar; 30(2):589.
Score: 0.002
-
Inhibition of JAK3 and STAT6 tyrosine phosphorylation by the immunosuppressive drug leflunomide leads to a block in IgG1 production. J Immunol. 1998 Feb 15; 160(4):1581-8.
Score: 0.002
-
Effect of anti-CD4 monoclonal antibody combined with human CTLA4Ig on the survival of hamster liver and heart xenografts in Lewis rats. Transplantation. 1997 Jul 27; 64(2):317-21.
Score: 0.002
-
Effect of leflunomide and cyclosporine on concordant xenogeneic islet transplantation in streptozotocin-induced and autoimmune diabetic mice. Transplant Proc. 1997 Jun; 29(4):2155.
Score: 0.002
-
Successful xenotransplantation of adult porcine islets in NOD and BALB/c mice with leflunomide and cyclosporine. Transplant Proc. 1997 Jun; 29(4):2166-7.
Score: 0.002
-
Gene gun-mediated gene transfer and expression in rat islets. Transplant Proc. 1997 Jun; 29(4):2209-10.
Score: 0.002
-
Prolongation of rat islet allograft survival by the immunosuppressive agent leflunomide. Transplantation. 1997 Mar 15; 63(5):711-6.
Score: 0.002
-
In vivo effects of leflunomide on normal pancreatic islet and syngeneic islet graft function. Transplantation. 1997 Mar 15; 63(5):716-21.
Score: 0.002
-
Leflunomide, a potential immunosuppressant for pancreatic islet transplantation. Transplant Proc. 1997 Feb-Mar; 29(1-2):1296-7.
Score: 0.002
-
Granulocyte colony-stimulating factor immunomodulation in the rat cardiac transplantation model. Transplantation. 1996 Apr 15; 61(7):1122-5.
Score: 0.002
-
Control and reversal of chronic xenograft rejection in hamster-to-rat cardiac transplantation. Transplant Proc. 1996 Apr; 28(2):691-2.
Score: 0.002
-
Cytotoxicity of prion protein peptide (PrP106-126) differs in mechanism from the cytotoxic activity of the Alzheimer's disease amyloid peptide, A beta 25-35. Neurodegeneration. 1996 Mar; 5(1):1-11.
Score: 0.002
-
Regulation of B cell function by the immunosuppressive agent leflunomide. Transplantation. 1996 Feb 27; 61(4):635-42.
Score: 0.002
-
Pharmacologically induced regression of chronic transplant rejection. Transplantation. 1995 Nov 27; 60(10):1065-72.
Score: 0.002
-
Inactivation of Kupffer cells after prolonged donor fasting improves viability of transplanted hepatic allografts. Hepatology. 1995 Oct; 22(4 Pt 1):1236-42.
Score: 0.002
-
Evidence for a dithiol-activated signaling pathway in natural killer cell avidity regulation of leukocyte function antigen-1: structural requirements and relationship to phorbol ester- and CD16-triggered pathways. Blood. 1995 Sep 15; 86(6):2288-301.
Score: 0.002
-
Improved viability of hepatic allografts from fasted donors is associated with decreased peripheral TNF activity. J Surg Res. 1995 Mar; 58(3):337-43.
Score: 0.002
-
Leflunomide controls rejection in hamster to rat cardiac xenografts. Transplantation. 1994 Oct 15; 58(7):828-34.
Score: 0.002
-
Effect of leflunomide in control of acute rejection in hamster-to-rat cardiac xenografts. Transplant Proc. 1994 Jun; 26(3):1263-5.
Score: 0.002
-
Leflunomide immunosuppression in rat small intestinal transplantation. Transplant Proc. 1994 Jun; 26(3):1599-600.
Score: 0.002
-
Allograft ultraviolet-B irradiation in rat small intestinal transplantation. Transplant Proc. 1994 Jun; 26(3):1624-5.
Score: 0.002
-
Immunosuppressive effects of leflunomide in a cardiac allograft model. Transplant Proc. 1993 Feb; 25(1 Pt 1):745-6.
Score: 0.001